编号：2015-001 证券代码：300334 证券简称：津膜科技 天津膜天膜科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|-------------------------------|-------------------------------------------------------| | | | | | 投资者关系活动 | 特定对象调研 □分析师会议 | | | 类别 | □媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 深圳市尊道投资有限公司 张应涛 | | | 人员姓名 | 国寿投资控股有限公司 吴雅婧 | | | | 民生证券 王宁 | | | | 信诚资本 魏华 | | | | 银河证券 邹序元 | | | | 银河证券 蒋昕昊 | | | 时间 | 2015 年 12 月 15 | 10:00-11:00 | | 地点 | 天津市河西区解放南路 | 256 号泰达大厦 18 层会议室 ...

编号：2016-001 证券代码：300334 证券简称：津膜科技 天津膜天膜科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|-------------------------|---------------------------------| | | | | | 投资者关系活动 | 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 安信证券 杨心成、邵琳琳 | | | 人员姓名 | 广发证券 邱长伟 | | | | 工银瑞信 孙楠 | | | | 上海沣杨资产 张楠 | | | | 英大资产 郭元庆 | | | | 博道投资 陈子木 | | | | 国都基金 张小强 | | | | 聚睿投资 汲亚飞 | | | | 国寿养老 黄锦超 | | | | 上海泓湖 邢达 | | | | 方正自营 卫子清 | | | | 深圳景泰利丰投资 刘虓虓 | | | ...

编号：2017-001 证券代码：300334 证券简称：津膜科技 天津膜天膜科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|---------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 东兴证券 庞天一 | | | 人员姓名 | 华泰证券 徐科 | | | | 光大证券 魏天野 | | | 时间 | 2017 年 1 月 | 14:00-15:00 | | 地点 | 天津市河西区解放南路 | 256 号泰达大厦 18 层 | | 上市公司接待人 | 副总经理兼董事会秘书 郝锴 | | | 员姓名 | | | | 投资者关系活动 | 一、互动问答 | | | ...

证券代码：300334 证券简称：津膜科技 编号：2017-002 天津膜天膜科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|-----------------------------------|---------------------------------------------| | | | | | 投资者关系活动 | 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 北京中环膜材料科技有限公司 张江英 | | | 人员姓名 | | 中国水务投资有限公司 汤德勤、赵海波、吕君为 | | | 东旭蓝天新能源股份有限公司 游跃 | | | | E20 环境平台 李斯 | | | | 山西证券 赵腾辉、张婉姝 | | | | 久期投资 黄征宇 | | | | 深圳市大岩资产管理有限公司 陈樟 | | | | | 中金公司 张钰淇、戚政韬、雒文 | | ...

Financial Performance - The company's revenue for Q3 2022 was ¥64,720,522.74, a decrease of 39.79% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥14,788,940.24, representing a decline of 463.97% year-on-year[5]. - The basic earnings per share were -¥0.05, down 600.00% from the previous year[5]. - Total operating revenue for Q3 2022 was ¥183,783,314.31, a decrease of 41.8% compared to ¥315,695,885.10 in Q3 2021[29]. - Operating profit for Q3 2022 was -¥38,492,173.12, compared to a profit of ¥20,635,400.94 in Q3 2021, indicating a significant decline[29]. - The net profit for Q3 2022 was -42,798,505.90 CNY, compared to a net profit of 19,067,671.70 CNY in the same period last year, indicating a significant decline[30]. - The company's total comprehensive income for the period was -42,798,505.90 CNY, compared to 19,067,671.70 CNY in the same period last year[30]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,549,438,051.99, a decrease of 2.24% from the end of the previous year[5]. - Non-current assets totaled ¥1,028,238,267.17, down from ¥1,052,334,148.70, a decrease of 2.3%[26]. - The company's total assets decreased to ¥1,549,438,051.99 from ¥1,585,013,039.67, reflecting a decline of 2.2%[27]. - Total current liabilities rose to ¥631,800,736.74 from ¥620,135,622.33, an increase of 2.7%[27]. - Total liabilities amounted to ¥747,106,292.88, slightly up from ¥746,145,102.04, indicating a marginal increase[27]. Cash Flow - The net cash flow from operating activities was 26,049,876.43 CNY, compared to 41,902,090.62 CNY in the previous year, representing a decline of about 37.8%[31]. - The company reported a cash and cash equivalents balance of 39,659,067.78 CNY at the end of the period, down from 70,974,136.89 CNY at the beginning of the period, a decrease of approximately 44%[32]. - The company incurred a total of 262,110,228.91 CNY in cash outflows from financing activities, compared to 269,590,584.93 CNY in the previous year, showing a slight decrease of about 2.5%[32]. Operating Costs and Income - The company reported a significant drop in operating income, which decreased by ¥131,912,600.79, or 41.78%, primarily due to the exclusion of Zhejiang Jinmo from the consolidated scope and the impact of the pandemic[14][15]. - Operating costs also fell by 31.06% year-on-year, amounting to ¥141,816,763.89[14]. - Total operating costs for Q3 2022 were ¥237,831,084.77, down from ¥304,115,686.58 in the same period last year, reflecting a reduction of 21.7%[29]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 21,753[18]. - The largest shareholder, Tianjin Membrane Engineering Technology Co., Ltd., holds 21.19% of shares, totaling 64,004,465 shares[18]. - The second-largest shareholder, Hua Yi Technology International, holds 10.40% of shares, totaling 31,409,000 shares[18]. - The top ten shareholders hold a significant portion of the company's shares, with the top three alone accounting for over 41%[18]. Legal and Regulatory Matters - The company is involved in a lawsuit regarding a sewage treatment project with a claim amount of RMB 17,977,994.12[22]. - The company has received an arbitration request for payment related to two engineering projects, including interest[21]. Future Plans and Investments - The company plans to provide a guarantee of RMB 450 million for its subsidiaries' financing needs over the next twelve months[20]. - High-tech Investment Development Co., Ltd. plans to reduce its holdings by up to 6,041,307 shares, representing 2% of the company's total share capital[23]. - The company has completed the transfer of actual control to the new management team as per the investment agreement[23].

证券代码：300334 证券简称：津膜科技 公告编码：2022-075 天津膜天膜科技股份有限公司 关于参加2022年度天津辖区上市公司半年报业绩说明会 与投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 为加强与广大投资者的交流沟通，天津膜天膜科技股份有限公司（以下简称 "公司"）定于2022年9月6日（周二）13:40-16:40 参加由天津证监局主办、天津 上市公司协会与深圳市全景网络有限公司协办的"2022年度天津辖区上市公司半 年报业绩说明会与投资者网上集体接待日"活动，本次活动将采用网络远程的方 式举行，投资者可登录"全景路演"（ http://rs.p5w.net）参与本次互动交流。 网上互动交流时间为 2022 年 9 月 6 日（星期二）下午 15:00-16:30。 出席本次"2022 年度天津辖区上市公司半年报业绩说明会与投资者网上集 体接待日"活动的人员有：公司董事长兼总经理范宁先生，副总经理兼董事会秘 书展树华先生，副总经理兼财务总监于建华先生。欢迎广大投资者积极参与。 特此公告！ 天津膜天膜科技股份有限 ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥119,062,791.57, a decrease of 42.81% compared to ¥208,197,972.20 in the same period last year[19]. - The net profit attributable to shareholders was -¥26,698,811.20, representing a decline of 371.57% from ¥9,831,374.05 in the previous year[19]. - The net cash flow from operating activities was ¥9,020,260.35, down 80.01% from ¥45,130,776.94 in the same period last year[19]. - The basic and diluted earnings per share were both -¥0.088, a decrease of 366.67% compared to ¥0.033 in the previous year[19]. - Total assets at the end of the reporting period were ¥1,556,511,147.53, a decrease of 1.80% from ¥1,585,013,039.67 at the end of the previous year[19]. - The net assets attributable to shareholders decreased by 3.47% to ¥743,788,020.13 from ¥770,486,831.33 at the end of the previous year[19]. - The company reported a total revenue of 1,504,648.17 yuan, reflecting a decrease of 5.85% compared to the previous period[42]. - The company reported a net loss of CNY 663,227,420.82, compared to a loss of CNY 636,528,609.62 in the previous period[178]. - The total comprehensive income for the first half of 2022 was a loss of CNY 26,476,879.94, compared to a profit of CNY 13,935,925.20 in the same period of 2021[185]. Revenue and Cost Management - Operating costs decreased by 27.86% to ¥92,798,104.78 from ¥128,629,469.09 in the previous year, reflecting improved cost management[36]. - Research and development expenses were ¥10,276,694.16, down 29.30% from ¥14,535,149.07, indicating a strategic focus on cost control amid revenue decline[36]. - The gross profit margin for specialized equipment manufacturing was 22.06%, a decrease of 16.16% compared to the previous year, reflecting the challenges in maintaining profitability amid declining revenues[38]. - The company's total investment during the reporting period was ¥4,774,773.96, a decrease of 80.45% compared to ¥24,422,601.05 in the same period last year[48]. - The company aims to reduce operational costs by 10% through efficiency improvements in the supply chain[102]. Market Position and Strategy - The company is primarily engaged in the R&D, production, and sales of ultrafiltration and microfiltration membranes and components, providing comprehensive solutions for water resource management[27]. - The company is facing intensified competition in the membrane product market, prompting a strategic shift to enhance product sales and value-added services[59]. - The company has a rich experience in project implementation across various sectors, including municipal, dyeing, petrochemical, and seawater desalination, which strengthens its market position[33]. - The company plans to expand its market presence in Southeast Asia, targeting a 15% market share by the end of 2023[101]. - A strategic acquisition of a local competitor is in progress, which is anticipated to increase the company's production capacity by 30%[102]. Research and Development - The company has established a strong R&D capability, supported by national key laboratories and various engineering design qualifications, enhancing its competitive edge in the membrane industry[32]. - The company plans to invest 200 million RMB in R&D for new technologies over the next two years[100]. - New product development includes the launch of a next-generation membrane technology expected to enhance efficiency by 10%[100]. - The company is exploring partnerships with international firms to leverage technology and expand its global footprint[109]. Environmental Compliance - The company is classified as a key pollutant discharge unit by environmental protection authorities[72]. - The company reported a total suspended solids discharge of 0.34 tons, with a concentration of 12 mg/L, compliant with discharge standards[72]. - The company has completed the construction of pollution prevention facilities, including various treatment pools and biological reaction pools, with stable compliance achieved[74]. - The company has implemented energy-saving measures, including replacing 20 streetlights with solar-powered lights and upgrading to LED lighting, which improves energy efficiency[80]. - The company has not faced any administrative penalties for environmental issues during the reporting period[79]. Governance and Compliance - The company has conducted several shareholder meetings, with participation rates ranging from 21.26% to 43.36%, ensuring stakeholder engagement in corporate governance[65]. - The company plans not to distribute cash dividends, issue bonus shares, or increase share capital from capital reserves for the half-year period[68]. - The company has committed to ensuring that it does not harm the interests of the listed company and its minority shareholders during the period of holding shares[90]. - The company has established a commitment to maintain effective communication and information disclosure regarding related party transactions[94]. - The company is focused on enhancing its governance structure to ensure compliance with related party transaction regulations[93]. Legal Matters - The company is currently involved in another lawsuit with a claim amount of 20.881 million yuan, which is still under trial in the Hebei Province Intermediate People's Court[120]. - The company has faced delays in payment from the defendant, leading to multiple legal actions to recover owed amounts[120]. - The company is awaiting the final judgment on the ongoing lawsuits, which may impact its future profits[120]. - The company is involved in a legal dispute with Tianjin Water Supply Construction Co., seeking payment of construction fees totaling CNY 270 million and interest, amounting to a total claim of CNY 297.69 million[123]. Future Outlook - The company provided a positive outlook for the second half of 2022, projecting a revenue growth of 20% to 30% based on current market trends and demand[102]. - The company has outlined a positive outlook for the future, projecting a revenue growth of 25% for the next fiscal year[105]. - The company plans to enhance its market expansion strategies and invest in new product development[198]. - The company has set a performance guidance for the next quarter, expecting a revenue growth of 10% year-over-year[200].

天津膜天膜科技股份有限公司 2022 年第一季度报告全文 证券代码：300334 证券简称：津膜科技 公告编号：2022-038 天津膜天膜科技股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带 的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明：保证季度报告中财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 59,232,541.62 | 63,040,375.95 | -6.04% | | 归属于上市公司股东的净利润（元） | -12,931,999.87 | 2,028 ...

Financial Performance - The company's operating revenue for 2021 was ¥473,336,155.34, a decrease of 5.81% compared to ¥502,523,635.86 in 2020[20] - The net profit attributable to shareholders in 2021 was ¥28,295,675.93, representing a significant increase of 132.35% from a loss of ¥87,472,161.51 in 2020[20] - The net profit after deducting non-recurring gains and losses was ¥5,968,865.64, up 106.13% from a loss of ¥97,421,499.66 in the previous year[20] - The net cash flow from operating activities was ¥70,856,510.64, down 55.23% from ¥158,270,237.94 in 2020[20] - Basic earnings per share for 2021 were ¥0.094, compared to a loss of ¥0.290 per share in 2020, marking a 132.41% improvement[20] - The total assets at the end of 2021 were ¥1,585,013,039.67, a decrease of 13.99% from ¥1,842,721,294.08 at the end of 2020[20] - The net assets attributable to shareholders increased by 3.81% to ¥770,486,831.33 from ¥742,191,155.40 in 2020[20] - The weighted average return on equity for 2021 was 3.74%, a significant recovery from -11.13% in 2020[20] Revenue Breakdown - Revenue from membrane engineering increased by 8.49% year-on-year, reaching ¥220,239,686.81, accounting for 46.53% of total revenue[42] - Sales revenue from membrane products decreased by 26.16% year-on-year to ¥124,254,287.70, representing 26.25% of total revenue[42] - The company reported a gross profit margin of 30.77% for the specialized equipment manufacturing industry, an increase of 5.79% from the previous year[44] - The sales volume of membrane components decreased by 37.62% year-on-year, totaling 1,900,145.6 square meters[44] Research and Development - The company has a strong R&D capability, supported by national key laboratories and various engineering design qualifications[37] - The company focuses on the development of ultra and microfiltration membranes and provides comprehensive solutions for water resource utilization[32] - The company is currently developing new products aimed at oil-water separation for offshore and port applications, with ongoing project acceptance[55] - The company is developing high-efficiency continuous adsorption and separation materials to expand its membrane technology applications[56] - The company aims to enhance the industrialization of domestic membrane products by developing large-scale seawater desalination and comprehensive utilization equipment[56] - The company's R&D investment amounted to ¥28,054,506.76 in 2021, representing 5.93% of operating revenue, a decrease from 8.02% in 2020[59] - The number of R&D personnel decreased by 33.94% to 109 in 2021, with a notable drop in the number of master's degree holders by 72.97%[59] Strategic Initiatives - The company is actively adjusting its business strategy in response to market changes and financial pressures due to the COVID-19 pandemic[39] - The company has implemented strict cost control measures to mitigate the impact of rising raw material prices[31] - The company is focusing on expanding its market presence in rural wastewater treatment through integrated MBR technology[58] - The company is exploring potential mergers and acquisitions to accelerate growth and expand its technological capabilities[101] - The company is committed to improving operational efficiency to support its growth objectives and enhance profitability[100] Governance and Management - The board of directors consists of nine members, including five independent directors, ensuring compliance with legal and regulatory requirements[92] - The company has established effective performance evaluation and incentive mechanisms for directors and senior management, aligning with its development status[94] - The company maintains independence from its controlling shareholder in terms of business, personnel, assets, and finance, ensuring autonomous operational capabilities[96] - The company has established a centralized management system covering all subsidiaries, focusing on financial, operational, and procurement standardization[86] - The company has established a performance evaluation system that links assessment results to employee compensation and career advancement decisions[167] Environmental Management - The company is classified as a key pollutant discharge unit by environmental protection authorities[195] - The total discharge of chemical oxygen demand (COD) is 6.23 tons, with a concentration of 139 mg/L, which complies with the pollution discharge standards[195] - The company has established pollution prevention facilities, which are currently operating stably and meeting discharge standards[197] - The wastewater treatment process utilizes a multi-mode AAO + deep bed filter technology, ensuring effective treatment[197] - The company has reported zero cases of exceeding the pollution discharge limits for all monitored pollutants[195] Future Outlook - The company has set ambitious performance guidance for the upcoming year, aiming for continued growth in revenue and market share[101] - Future outlook remains positive, with expectations of sustained demand for the company's products in the market[101] - The company is focusing on expanding its market presence, particularly in the water treatment sector, aiming for a 30% market share by 2025[109] - The company plans to explore strategic acquisitions to enhance its technology capabilities and market reach, targeting at least two acquisitions in the next fiscal year[109]

天津膜天膜科技股份有限公司 2021 年第三季度报告 证券代码：300334 证券简称：津膜科技 公告编号：2021-087 天津膜天膜科技股份有限公司 2021 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中 财务信息的真实、准确、完整。 3.第三季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 本报告期比上年同期增 | 年初至报告期末 | 年初至报告期末比上年 | | --- | --- | --- | --- | --- | | | | 减 | | 同期增减 | | 营业收入（元） | 107,497,912.90 | -22.24% | 315,695,885.10 | 5.1 ...